What will it take to develop new drugs for Lyme disease?
Dr. Raphael Stricker, a San Francisco internist and hematologist, is an internationally recognized leader in tick-borne disease diagnosis and treatment.
He is also a board member of LymeDisease.org.
Dr. Stricker recently delivered a recorded overview of tick-borne diseases to the European Society of Medicine Congress 2021. The title of his talk was “Lyme Disease: The New Pharma Frontier.”
As he notes in his introduction,
“Over the past year, there have been at least four novel antiviral drugs for Covid-19 that have been developed. It’s disappointing that we haven’t seen the same kind of drug development for Lyme disease over the years. [In this presentation], I’d like to focus on that type of drug development.”
Click below to view his talk.
To answer the question: we, the sick, must do it ourselves.
- WARNING: Disulfiram can cause psychosis in a subset of people. I was one of them: https://madisonarealymesupportgroup.com/2019/10/14/november-2019-lyme-support-meeting-oct-meeting-canceled-due-to-reaction-to-disulfiram/
- https://madisonarealymesupportgroup.com/2019/10/15/disulfiram-psychosis-update/ While not fun, I’m glad I used it and went through this so I can serve as a warning to others – particularly single patients. I would not recommend this drug unless you have family/friends around you. When you go nuts, you don’t know it. The psychosis is very real. Since disulfiram has such a long half-life, it stays in your body for a long time. The anti-psychotics to reverse the effects are riddled with side-effects. I spent $20K in the UW hospital with the most severe toxic reaction to disulfiram they have ever seen. “Mad as a hatter” doesn’t even describe it. I’ve spoken with local Lyme literate doctors whom have all had patients go South on it, so it wasn’t just me.